We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Actinic Keratoses With Photodynamic Therapy Using Sunlight Versus Red Light

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00432224
First Posted: February 7, 2007
Last Update Posted: February 7, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Bispebjerg Hospital
  Purpose
The objective of the study is to evaluate the use of sunlight instead of red light during photodynamic therapy of actinic keratoses using methyl aminolevulinate

Condition Intervention
Actinic Keratoses Procedure: photodynamic therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by Bispebjerg Hospital:

Estimated Enrollment: 28
Study Start Date: May 2006
Estimated Study Completion Date: February 2007
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • symmetric actinic keratoses in scalp or face

Exclusion Criteria:

  • porphyria, pregnancy, breast feeding
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00432224


Locations
Denmark
Bispebjerg Hospital
Copenhagen NV, Denmark, 2400
Sponsors and Collaborators
Bispebjerg Hospital
Investigators
Study Director: Hans Christian Wulf, Professor, MD Bispebjerg Hospital
Study Chair: Merete Hædersdal, MD, PhD Bispebjerg Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00432224     History of Changes
Other Study ID Numbers: KF 01-272867
First Submitted: February 6, 2007
First Posted: February 7, 2007
Last Update Posted: February 7, 2007
Last Verified: February 2007

Additional relevant MeSH terms:
Keratosis
Keratosis, Actinic
Skin Diseases
Precancerous Conditions
Neoplasms